Compare
GenFlat Holdings, Inc. vs Hestia Insight Inc. vs Balance Labs, Inc. vs Bodhi Tree Biotechnology Inc
| Latest fiscal year | GenFlat Holdings, Inc. GFLT | Hestia Insight Inc. HSTA | Balance Labs, Inc. BLNC | Bodhi Tree Biotechnology Inc BDTB |
|---|---|---|---|---|
| Year ended | 2025-06-30 | 2025-11-30 | 2025-12-31 | 2025-09-30 |
| Revenue | $7.9K | $8.0K | $6.0K | $17.0K |
| Revenue growth (YoY) | +50.8% | -99.4% | n/a | n/a |
| Gross margin | n/m | n/a | 100.0% | n/a |
| Operating margin | n/m | n/m | n/m | -868.3% |
| Net margin | n/m | n/m | n/m | -880.4% |
| Net income | -$4.67M | -$943.4K | -$31.77M | -$149.7K |
| EPS (Diluted) | -$0.44 | $0.02 | -$1.23 | -$0.01 |
| Operating cash flow | -$1.18M | -$134.3K | -$257.0K | -$150.2K |
| Free cash flow | -$1.18M | n/a | n/a | n/a |
| Cash & equivalents | n/a | n/a | $359.0K | n/a |
| Total assets | $686.1K | $395.1K | $397.5K | $119.2K |
| Total liabilities | $394.0K | $278.2K | $3.77M | n/a |
| Shareholders' equity | $295.5K | $116.9K | -$3.38M | $119.2K |
| Return on year-end equity | n/m | -807.1% | n/a | -125.6% |
| Shares outstanding | 10.72M | 27.94M | 46.85M | 25.44M |
Revenue, most recent five fiscal years
| Fiscal year | GenFlat Holdings, Inc. | Hestia Insight Inc. | Balance Labs, Inc. | Bodhi Tree Biotechnology Inc |
|---|---|---|---|---|
| Latest | $7.9K Ended 2025-06-30 | $8.0K Ended 2025-11-30 | $6.0K Ended 2025-12-31 | $17.0K Ended 2025-09-30 |
| 1 year earlier | $5.2K Ended 2024-06-30 | $1.25M Ended 2024-11-30 | n/a | n/a |
| 2 years earlier | $0 Ended 2023-06-30 | $113.4K Ended 2023-11-30 | n/a | n/a |
| 3 years earlier | n/a | $15.0K Ended 2022-11-30 | $247.5K Ended 2022-12-31 | n/a |
| 4 years earlier | n/a | $28.5K Ended 2021-11-30 | $624.6K Ended 2021-12-31 | n/a |